RNATICS develops therapeutics that target disease-causing RNAs in tissue macrophages, which provide tremendous therapeutic opportunities for multiple diseases. Our Vision is to employ the unique natural phagocytic properties of tissue resident macrophages as an effective means of delivery to gain access to organs previously not accessible to nucleic acid therapeutics.
| Website | https://rnatics.com/ |
| Employees | 6 (2 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Rna Therapeutics, Molecular Medicine, Rna Biology, Rna Based Therapies, Precision Medicine, Drug Discovery, Biotechnology, Targeted Therapies, Pharmaceutical Research, Innovative Therapeutics, New Therapies, Immunology, Clinical Development |
| Competitors | GE HealthCare, Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Zymo Research Corp, Fisher BioServices +48 more (view full list) |
Looking for a particular RNATICS employee's phone or email?
RNATICS Questions
Thomas Frischmuth is the CEO of RNATICS.
2 people are employed at RNATICS.
Top RNATICS Employees
-
Thomas Frischmuth
Chief Executive Officer at RNATICS
Hamburg, HH, DE42 -
2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
